Synthetic Biology grants in the United States

Between cycles

Supports clinical rare-disease teams with practical trial design and execution.

Closed

Funds organizations conducting clinical trials of vaccine candidates against CEPI priority pathogens and viral families through CEPI's Innovations Call for Proposals.

Closed

Awards 15,000 Euro plus exhibition space and mentoring to the winning early-stage company at the ACHEMA Start-up Award 2027, for new ventures in chemistry, process engineering or biotechnology.

Closed

Supports biosecurity research, policy work, and prevention planning for pandemic preparedness.

Closed

Funds preclinical translational research advancing therapies for inherited retinal degeneration and dry AMD.

Closed

Funds organizations designing and early-stage testing of new vaccine candidates against CEPI priority pathogens and Disease X viral families, with awards up to $1M over 18 months.

Closed

Funds organizations conducting preclinical vaccine development for CEPI priority pathogens and Disease X exemplars through CEPI's Innovations call.

Closed

Funds accredited research institutions developing treatments for congenital dystroglycanopathies with grants up to $50,000.

Closed

Funds accredited research institutions developing treatments and care improvements for congenital-onset laminopathies with grants up to $100,000.

Closed

Funds global teams developing drug, biologic, dietary, or microbiome-based interventions that target placental and gut inflammatory pathways to improve fetal growth outcomes in low-income countries.

Closed

Supports United Kingdom human organ engineering collaborations focused on translational tissue platforms.

Closed

Funds developing and validating gene-editing tools in animal and other model systems used to study the human brain.

Closed

Runs a 10-week, no-cost, non-dilutive accelerator for early-stage security, resiliency, and dual-use founders, from Pre-Seed through Series A+, culminating in enterprise pilots and investor-ready pitches.

Closed

Funds global teams researching novel approaches to overcome infection, inflammation, and microbiome-related barriers that reduce the effectiveness of food fortification programs.

Open

Offers pitch time, mentoring and investor exposure to five category-winning startups.

Open

Awards up to $250,000 in cash and in-kind prizes to Tufts-affiliated founders.

Open

Offers qualifying open-source projects free full Datadog access to support monitoring and reliability operations.

Open

Provides venture studio support, go-to-market coaching, and startup growth services through cohort engagement.

Scheduled

Funds secondments of staff between partner organisations worldwide so researchers and R&I staff gain cross-sector, cross-country and cross-discipline experience.

Scheduled

Pays a postdoctoral researcher's fellowship at a host organisation in Europe, or abroad with a mandatory return phase, to build international research experience.

Between cycles

Backs startups setting up and scaling their business in Spain.

Between cycles

Funds organisations worldwide developing novel defence and security innovations across any technology area from TRL 1 to TRL 8.

Between cycles

Offers breakthrough hardware startups coaching and up to €4,000 in travel support.

Between cycles

Offers early-stage founders startup credits for compute on AWS so teams can prototype and launch without immediate spend.